Gene Symbol | Gene ID | Gene Info |
---|---|---|
Etv4
|
ENSMUSG00000017724.8 | ets variant 4 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_101785577_101785749 | Etv4 | 292 | 0.883361 | 0.52 | 5.3e-05 | Click! |
chr11_101784669_101785516 | Etv4 | 130 | 0.953215 | 0.47 | 2.8e-04 | Click! |
chr11_101814890_101815041 | Etv4 | 29594 | 0.120010 | 0.40 | 2.6e-03 | Click! |
chr11_101784474_101784652 | Etv4 | 72 | 0.966533 | 0.29 | 3.1e-02 | Click! |
chr11_101821047_101821198 | Etv4 | 35751 | 0.107660 | -0.29 | 3.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr13_112695608_112695943 | 202.62 |
Gm18883 |
predicted gene, 18883 |
3904 |
0.16 |
chr3_134339308_134339650 | 118.85 |
Gm43558 |
predicted gene 43558 |
17813 |
0.17 |
chr12_3236518_3237725 | 96.17 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
510 |
0.74 |
chr9_124439906_124440949 | 92.17 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
441 |
0.79 |
chr8_47003593_47003771 | 69.65 |
Gm45600 |
predicted gene 45600 |
10495 |
0.17 |
chr6_54313454_54313605 | 59.86 |
Prr15 |
proline rich 15 |
12306 |
0.16 |
chr8_47004297_47004459 | 58.06 |
Gm45600 |
predicted gene 45600 |
9799 |
0.17 |
chr14_14350947_14351733 | 57.03 |
Il3ra |
interleukin 3 receptor, alpha chain |
1719 |
0.23 |
chrX_170675440_170675591 | 52.72 |
Asmt |
acetylserotonin O-methyltransferase |
2871 |
0.39 |
chr15_101995547_101995886 | 51.17 |
Gm36026 |
predicted gene, 36026 |
8496 |
0.11 |
chr8_47003974_47004154 | 50.58 |
Gm45600 |
predicted gene 45600 |
10113 |
0.17 |
chr5_32713265_32714499 | 47.67 |
Gm43852 |
predicted gene 43852 |
106 |
0.94 |
chrX_75673394_75674325 | 46.81 |
Gm15065 |
predicted gene 15065 |
31550 |
0.13 |
chrX_170674987_170675201 | 40.12 |
Asmt |
acetylserotonin O-methyltransferase |
2450 |
0.42 |
chr8_47003312_47003463 | 33.55 |
Gm45600 |
predicted gene 45600 |
10790 |
0.17 |
chr12_3237774_3237992 | 32.93 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
1272 |
0.39 |
chr6_100399458_100399609 | 31.78 |
Gm23234 |
predicted gene, 23234 |
95281 |
0.06 |
chr12_3238767_3239202 | 29.49 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
2373 |
0.24 |
chr14_14349604_14349813 | 29.29 |
Il3ra |
interleukin 3 receptor, alpha chain |
87 |
0.94 |
chr14_14347096_14348750 | 28.76 |
Gm48860 |
predicted gene, 48860 |
659 |
0.44 |
chr14_106164218_106164369 | 26.04 |
Gm48971 |
predicted gene, 48971 |
47685 |
0.12 |
chr5_109556763_109557843 | 25.51 |
Crlf2 |
cytokine receptor-like factor 2 |
830 |
0.53 |
chr14_14349938_14350878 | 24.66 |
Il3ra |
interleukin 3 receptor, alpha chain |
787 |
0.48 |
chr14_106163676_106163827 | 23.57 |
Gm48971 |
predicted gene, 48971 |
48227 |
0.12 |
chr14_14349400_14349589 | 23.45 |
Il3ra |
interleukin 3 receptor, alpha chain |
127 |
0.93 |
chr15_30383087_30383401 | 21.25 |
Gm49283 |
predicted gene, 49283 |
45600 |
0.17 |
chr8_4677704_4678740 | 21.17 |
Gm7461 |
predicted gene 7461 |
143 |
0.62 |
chrX_170675926_170676102 | 19.31 |
Asmt |
acetylserotonin O-methyltransferase |
3370 |
0.36 |
chr12_3234876_3235557 | 17.64 |
Rab10os |
RAB10, member RAS oncogene family, opposite strand |
288 |
0.88 |
chr6_71925272_71925574 | 15.77 |
Polr1a |
polymerase (RNA) I polypeptide A |
671 |
0.56 |
chr7_35456565_35456716 | 15.53 |
Slc7a9 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 |
6804 |
0.13 |
chr14_14345884_14346978 | 14.80 |
Il3ra |
interleukin 3 receptor, alpha chain |
1 |
0.93 |
chr1_7395531_7395712 | 14.55 |
Gm26901 |
predicted gene, 26901 |
2174 |
0.32 |
chr4_126850161_126850502 | 14.50 |
AU040320 |
expressed sequence AU040320 |
186 |
0.92 |
chr2_174472333_174473544 | 14.28 |
Prelid3b |
PRELI domain containing 3B |
4 |
0.96 |
chr5_109554227_109554566 | 13.82 |
Gm8493 |
predicted gene 8493 |
240 |
0.89 |
chr13_84449354_84449551 | 13.63 |
Gm26927 |
predicted gene, 26927 |
109339 |
0.06 |
chr9_124439329_124439899 | 13.51 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
1254 |
0.4 |
chr1_20819843_20820501 | 13.38 |
Mcm3 |
minichromosome maintenance complex component 3 |
88 |
0.93 |
chr6_13836676_13836883 | 12.67 |
Gpr85 |
G protein-coupled receptor 85 |
462 |
0.83 |
chr7_7278018_7278547 | 12.41 |
Gm45844 |
predicted gene 45844 |
7 |
0.49 |
chr15_103518626_103518966 | 11.98 |
Pde1b |
phosphodiesterase 1B, Ca2+-calmodulin dependent |
3876 |
0.17 |
chr4_109977849_109978740 | 11.64 |
Dmrta2 |
doublesex and mab-3 related transcription factor like family A2 |
241 |
0.73 |
chr1_25892463_25892638 | 11.62 |
Gm9884 |
predicted gene 9884 |
61893 |
0.08 |
chr13_83721535_83721983 | 11.51 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
378 |
0.8 |
chr7_44405306_44405805 | 11.29 |
Gm45124 |
predicted gene 45124 |
19155 |
0.06 |
chr8_12126295_12126640 | 11.16 |
A230072I06Rik |
RIKEN cDNA A230072I06 gene |
152352 |
0.03 |
chr7_18950757_18950953 | 11.10 |
Nova2 |
NOVA alternative splicing regulator 2 |
24967 |
0.07 |
chr17_52601056_52601789 | 10.95 |
Gm27217 |
predicted gene 27217 |
1238 |
0.39 |
chr14_106163988_106164139 | 10.77 |
Gm48971 |
predicted gene, 48971 |
47915 |
0.12 |
chr1_42691969_42692512 | 10.68 |
Pantr1 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 1 |
853 |
0.48 |
chr7_75868535_75868959 | 10.57 |
Klhl25 |
kelch-like 25 |
20306 |
0.21 |
chr5_109553254_109553474 | 10.43 |
Gm8493 |
predicted gene 8493 |
792 |
0.55 |
chr4_44519102_44519253 | 10.43 |
Mir5120 |
microRNA 5120 |
88391 |
0.07 |
chr16_14265466_14265813 | 10.41 |
Myh11 |
myosin, heavy polypeptide 11, smooth muscle |
25724 |
0.14 |
chr18_47647195_47647522 | 10.41 |
Gm5236 |
predicted gene 5236 |
82409 |
0.08 |
chr7_73637071_73637452 | 10.29 |
Gm44737 |
predicted gene 44737 |
6644 |
0.1 |
chr7_4920995_4921327 | 10.19 |
Nat14 |
N-acetyltransferase 14 |
867 |
0.32 |
chr3_4797268_4797439 | 10.18 |
1110015O18Rik |
RIKEN cDNA 1110015O18 gene |
205 |
0.96 |
chr3_21356267_21356490 | 10.17 |
Gm29137 |
predicted gene 29137 |
87288 |
0.1 |
chr5_129260821_129260972 | 10.16 |
Gm43001 |
predicted gene 43001 |
102666 |
0.07 |
chr12_65428316_65428602 | 10.16 |
Gm26015 |
predicted gene, 26015 |
22489 |
0.22 |
chr3_20776476_20776661 | 9.97 |
Gm18491 |
predicted gene, 18491 |
7495 |
0.19 |
chr8_8037970_8038121 | 9.90 |
Gm31401 |
predicted gene, 31401 |
28621 |
0.21 |
chr8_121301989_121302140 | 9.67 |
Gm26815 |
predicted gene, 26815 |
54772 |
0.12 |
chr4_22835787_22836371 | 9.66 |
Gm24078 |
predicted gene, 24078 |
88948 |
0.09 |
chr16_7419786_7419980 | 9.65 |
Rbfox1 |
RNA binding protein, fox-1 homolog (C. elegans) 1 |
66913 |
0.15 |
chr8_120217063_120217433 | 9.62 |
A330074K22Rik |
RIKEN cDNA A330074K22 gene |
10982 |
0.16 |
chr2_65668417_65668738 | 9.62 |
Scn2a |
sodium channel, voltage-gated, type II, alpha |
109 |
0.98 |
chr13_52457883_52458068 | 9.55 |
Diras2 |
DIRAS family, GTP-binding RAS-like 2 |
73304 |
0.12 |
chr9_124425098_124425344 | 9.45 |
Ppp2r3d |
protein phosphatase 2 (formerly 2A), regulatory subunit B'', delta |
1067 |
0.46 |
chr11_102779956_102780107 | 9.40 |
Adam11 |
a disintegrin and metallopeptidase domain 11 |
3477 |
0.15 |
chr5_104109154_104109490 | 9.38 |
Gm26703 |
predicted gene, 26703 |
31 |
0.96 |
chr8_12915219_12915955 | 9.22 |
Gm15351 |
predicted gene 15351 |
32 |
0.8 |
chr6_28842333_28842923 | 9.12 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
6279 |
0.2 |
chrY_90744335_90744901 | 9.06 |
Mid1-ps1 |
midline 1, pseudogene 1 |
8439 |
0.18 |
chr10_29856047_29856198 | 9.05 |
Gm6390 |
predicted gene 6390 |
74711 |
0.1 |
chr3_17788380_17788641 | 9.04 |
Mir124-2hg |
Mir124-2 host gene (non-protein coding) |
1411 |
0.41 |
chr5_106560658_106561014 | 9.02 |
Gm28050 |
predicted gene, 28050 |
13879 |
0.14 |
chr1_12577055_12577225 | 9.02 |
Gm2383 |
predicted gene 2383 |
11563 |
0.24 |
chr14_25401486_25402359 | 9.01 |
Gm26660 |
predicted gene, 26660 |
22313 |
0.15 |
chr18_57262780_57262931 | 8.96 |
Gm50200 |
predicted gene, 50200 |
52285 |
0.11 |
chr14_4335584_4335754 | 8.95 |
2610042L04Rik |
RIKEN cDNA 2610042L04 gene |
906 |
0.48 |
chrX_110814092_110814465 | 8.91 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
2 |
0.98 |
chr10_29143863_29144732 | 8.91 |
Gm9996 |
predicted gene 9996 |
103 |
0.69 |
chr3_98990771_98991097 | 8.86 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
49678 |
0.1 |
chr15_8659416_8659937 | 8.84 |
Gm37310 |
predicted gene, 37310 |
4603 |
0.23 |
chr7_139140415_139140566 | 8.81 |
Stk32c |
serine/threonine kinase 32C |
48027 |
0.1 |
chr18_87922250_87922432 | 8.79 |
Gm24987 |
predicted gene, 24987 |
3223 |
0.36 |
chr4_71840383_71840625 | 8.77 |
Gm11233 |
predicted gene 11233 |
27484 |
0.23 |
chr16_87001357_87001526 | 8.72 |
Gm38477 |
predicted gene, 38477 |
22356 |
0.25 |
chr8_25969482_25969806 | 8.72 |
Hgsnat |
heparan-alpha-glucosaminide N-acetyltransferase |
2584 |
0.2 |
chr1_84697131_84697295 | 8.71 |
Dner |
delta/notch-like EGF repeat containing |
992 |
0.41 |
chr13_107676595_107677067 | 8.70 |
1700006H21Rik |
RIKEN cDNA 1700006H21 gene |
10566 |
0.23 |
chr1_47163860_47164031 | 8.63 |
Gm28826 |
predicted gene 28826 |
10484 |
0.28 |
chr1_46830543_46830706 | 8.62 |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
5275 |
0.22 |
chr19_33761590_33762005 | 8.58 |
Lipo3 |
lipase, member O3 |
154 |
0.94 |
chr9_41375999_41376652 | 8.57 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
4 |
0.98 |
chr8_6606923_6607199 | 8.55 |
Gm44844 |
predicted gene 44844 |
169317 |
0.04 |
chr14_5002054_5002241 | 8.54 |
Gm3298 |
predicted gene 3298 |
13744 |
0.13 |
chr9_13246797_13247848 | 8.50 |
Ccdc82 |
coiled-coil domain containing 82 |
340 |
0.82 |
chr19_33589843_33590299 | 8.50 |
AC141640.1 |
renalase, FAD-dependent amine oxidase (Rnls) pseudogene |
64 |
0.72 |
chr3_85300229_85300586 | 8.42 |
1700036G14Rik |
RIKEN cDNA 1700036G14 gene |
17112 |
0.24 |
chr7_81494080_81494231 | 8.42 |
Ap3b2 |
adaptor-related protein complex 3, beta 2 subunit |
230 |
0.87 |
chrX_152198430_152198581 | 8.40 |
Iqsec2 |
IQ motif and Sec7 domain 2 |
19541 |
0.17 |
chr7_129664007_129664606 | 8.38 |
Gm33248 |
predicted gene, 33248 |
3099 |
0.26 |
chr3_39047740_39047911 | 8.37 |
Gm43539 |
predicted gene 43539 |
38144 |
0.19 |
chr12_70368116_70368285 | 8.35 |
Trim9 |
tripartite motif-containing 9 |
20586 |
0.17 |
chr8_25392710_25392901 | 8.33 |
Gm39147 |
predicted gene, 39147 |
6215 |
0.16 |
chr12_29547825_29548188 | 8.32 |
Myt1l |
myelin transcription factor 1-like |
12784 |
0.23 |
chr10_58227289_58228680 | 8.30 |
Gm10807 |
predicted gene 10807 |
667 |
0.56 |
chr4_116016940_116018214 | 8.28 |
Faah |
fatty acid amide hydrolase |
98 |
0.95 |
chr2_6594788_6595061 | 8.27 |
Celf2 |
CUGBP, Elav-like family member 2 |
2124 |
0.42 |
chr3_68794461_68794612 | 8.25 |
Gm35584 |
predicted gene, 35584 |
33041 |
0.11 |
chr14_7026368_7026687 | 8.24 |
Gm10406 |
predicted gene 10406 |
922 |
0.48 |
chr1_194721621_194721772 | 8.16 |
2900035J10Rik |
RIKEN cDNA 2900035J10 gene |
11011 |
0.17 |
chr10_58652100_58652389 | 8.15 |
Edar |
ectodysplasin-A receptor |
23410 |
0.16 |
chr18_8871292_8871740 | 8.14 |
Gm37148 |
predicted gene, 37148 |
56719 |
0.14 |
chr1_77823898_77824072 | 8.13 |
Gm26263 |
predicted gene, 26263 |
74461 |
0.12 |
chr14_3572832_3573073 | 8.13 |
Gm3005 |
predicted gene 3005 |
929 |
0.5 |
chr14_12388536_12388712 | 8.12 |
Cadps |
Ca2+-dependent secretion activator |
11345 |
0.13 |
chr3_107887648_107888104 | 8.11 |
Gm43745 |
predicted gene 43745 |
1910 |
0.14 |
chr14_4416325_4416500 | 8.11 |
Gm3164 |
predicted gene 3164 |
964 |
0.43 |
chr8_47333020_47333194 | 8.10 |
Stox2 |
storkhead box 2 |
19241 |
0.22 |
chr2_59562684_59563070 | 8.09 |
Gm13552 |
predicted gene 13552 |
1807 |
0.42 |
chr6_66398799_66398950 | 8.09 |
Gm44233 |
predicted gene, 44233 |
128 |
0.54 |
chr13_69373219_69373370 | 8.03 |
Gm35514 |
predicted gene, 35514 |
22289 |
0.16 |
chr14_44912924_44913077 | 8.02 |
Gm18524 |
predicted gene, 18524 |
7252 |
0.1 |
chr11_6606254_6606619 | 8.01 |
Nacad |
NAC alpha domain containing |
383 |
0.7 |
chr7_144283778_144283985 | 8.00 |
Shank2 |
SH3 and multiple ankyrin repeat domains 2 |
558 |
0.83 |
chr14_5071833_5072096 | 8.00 |
Gm8281 |
predicted gene, 8281 |
924 |
0.48 |
chr14_7487575_7487737 | 7.98 |
Gm3752 |
predicted gene 3752 |
3894 |
0.17 |
chr6_28878059_28878560 | 7.97 |
Snd1 |
staphylococcal nuclease and tudor domain containing 1 |
1734 |
0.4 |
chr14_4111363_4111605 | 7.96 |
Gm8108 |
predicted gene 8108 |
958 |
0.46 |
chr8_28602186_28602351 | 7.95 |
Gm26795 |
predicted gene, 26795 |
8736 |
0.28 |
chr7_79514073_79514898 | 7.94 |
Mir9-3hg |
Mir9-3 host gene |
747 |
0.39 |
chr14_4500076_4500253 | 7.90 |
Gm3173 |
predicted gene 3173 |
14594 |
0.11 |
chr1_158401095_158401248 | 7.88 |
Gm37861 |
predicted gene, 37861 |
25235 |
0.18 |
chr14_3949713_3949978 | 7.88 |
Gm3095 |
predicted gene 3095 |
13702 |
0.11 |
chr5_144086615_144086766 | 7.85 |
Lmtk2 |
lemur tyrosine kinase 2 |
13746 |
0.13 |
chr14_3810787_3811147 | 7.84 |
Gm3002 |
predicted gene 3002 |
893 |
0.48 |
chr2_38425074_38425256 | 7.83 |
Gm13589 |
predicted gene 13589 |
1163 |
0.43 |
chr14_13355541_13355692 | 7.82 |
Gm15913 |
predicted gene 15913 |
1536 |
0.5 |
chr1_194030707_194030867 | 7.80 |
Gm21362 |
predicted gene, 21362 |
163778 |
0.04 |
chr3_105538840_105539458 | 7.80 |
Gm43847 |
predicted gene 43847 |
36242 |
0.16 |
chr14_16200359_16200518 | 7.79 |
Rpl31-ps3 |
ribosomal protein L31, pseudogene 3 |
24585 |
0.12 |
chr6_134888824_134888980 | 7.78 |
Gpr19 |
G protein-coupled receptor 19 |
1070 |
0.35 |
chr14_5740487_5740801 | 7.78 |
Gm3373 |
predicted gene 3373 |
933 |
0.44 |
chr8_78624131_78624282 | 7.76 |
Gm2253 |
predicted gene 2253 |
19912 |
0.2 |
chr2_154421078_154421682 | 7.76 |
Snta1 |
syntrophin, acidic 1 |
13281 |
0.16 |
chr8_94994579_94995017 | 7.73 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
37 |
0.96 |
chr1_81043310_81043461 | 7.73 |
Nyap2 |
neuronal tyrosine-phophorylated phosphoinositide 3-kinase adaptor 2 |
33565 |
0.22 |
chr18_15552342_15552493 | 7.72 |
Aqp4 |
aquaporin 4 |
141435 |
0.04 |
chr15_44707069_44707237 | 7.72 |
Sybu |
syntabulin (syntaxin-interacting) |
40635 |
0.15 |
chr3_19630099_19630367 | 7.72 |
1700064H15Rik |
RIKEN cDNA 1700064H15 gene |
1556 |
0.34 |
chr14_7173539_7173699 | 7.72 |
Gm3512 |
predicted gene 3512 |
914 |
0.5 |
chr4_54945565_54946178 | 7.71 |
Zfp462 |
zinc finger protein 462 |
823 |
0.73 |
chr3_53761473_53761661 | 7.67 |
C820005J03Rik |
RIKEN cDNA C820005J03 gene |
4836 |
0.18 |
chr1_25430627_25430827 | 7.66 |
Gm25294 |
predicted gene, 25294 |
20344 |
0.17 |
chr13_59091234_59091385 | 7.65 |
4930415C11Rik |
RIKEN cDNA 4930415C11 gene |
7216 |
0.18 |
chr14_3652817_3653110 | 7.65 |
Gm3020 |
predicted gene 3020 |
933 |
0.45 |
chr7_51339973_51340169 | 7.64 |
Gm45002 |
predicted gene 45002 |
54758 |
0.15 |
chr3_108410783_108411013 | 7.64 |
Celsr2 |
cadherin, EGF LAG seven-pass G-type receptor 2 |
4654 |
0.1 |
chr6_97616874_97617122 | 7.63 |
Frmd4b |
FERM domain containing 4B |
531 |
0.79 |
chr16_37991132_37991563 | 7.59 |
Gm25140 |
predicted gene, 25140 |
11260 |
0.21 |
chr1_52524166_52524337 | 7.59 |
Gm553 |
predicted gene 553 |
1349 |
0.3 |
chr16_31326340_31326629 | 7.57 |
AV205837 |
expressed sequence AV205837 |
1249 |
0.31 |
chr15_62902738_62902926 | 7.55 |
Tsg101-ps |
tumor susceptibility gene 101, pseudogene |
77816 |
0.11 |
chr2_70168982_70169214 | 7.54 |
Myo3b |
myosin IIIB |
72800 |
0.1 |
chr14_6037130_6037453 | 7.52 |
Gm8206 |
predicted gene 8206 |
918 |
0.4 |
chr5_20141168_20141319 | 7.50 |
Gm25761 |
predicted gene, 25761 |
26796 |
0.19 |
chr10_92092143_92092294 | 7.49 |
Rmst |
rhabdomyosarcoma 2 associated transcript (non-coding RNA) |
11571 |
0.2 |
chr14_6888825_6889165 | 7.48 |
Gm3667 |
predicted gene 3667 |
967 |
0.55 |
chr8_28744679_28744842 | 7.46 |
Gm26795 |
predicted gene, 26795 |
151228 |
0.04 |
chr3_110011351_110011581 | 7.45 |
Gm12535 |
predicted gene 12535 |
104082 |
0.07 |
chr6_111844284_111844601 | 7.45 |
Gm22093 |
predicted gene, 22093 |
241190 |
0.02 |
chr10_60029073_60029224 | 7.44 |
Ascc1 |
activating signal cointegrator 1 complex subunit 1 |
25821 |
0.15 |
chr14_115406601_115406770 | 7.43 |
4930505G20Rik |
RIKEN cDNA 4930505G20 gene |
2867 |
0.4 |
chr6_48628419_48628811 | 7.41 |
AI854703 |
expressed sequence AI854703 |
680 |
0.42 |
chr7_64741665_64742004 | 7.39 |
Apba2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
2005 |
0.39 |
chr13_80962745_80963559 | 7.39 |
9330111N05Rik |
RIKEN cDNA 9330111N05 gene |
264 |
0.71 |
chr13_6642470_6642834 | 7.38 |
Pfkp |
phosphofructokinase, platelet |
6002 |
0.2 |
chr16_14906813_14906989 | 7.37 |
Efcab1 |
EF-hand calcium binding domain 1 |
236 |
0.95 |
chr5_29735522_29736024 | 7.35 |
Dnajb6 |
DnaJ heat shock protein family (Hsp40) member B6 |
85 |
0.61 |
chr1_42261983_42262134 | 7.35 |
Gm28175 |
predicted gene 28175 |
201 |
0.94 |
chr6_28184853_28185004 | 7.35 |
Gm42547 |
predicted gene 42547 |
29877 |
0.13 |
chr6_51848852_51849022 | 7.31 |
Skap2 |
src family associated phosphoprotein 2 |
22992 |
0.22 |
chr5_65950673_65951149 | 7.31 |
4930480C01Rik |
RIKEN cDNA 4930480C01 gene |
394 |
0.76 |
chr16_29837376_29837556 | 7.31 |
Gm32679 |
predicted gene, 32679 |
2738 |
0.29 |
chr13_99516425_99517155 | 7.31 |
Gm26559 |
predicted gene, 26559 |
161 |
0.62 |
chr6_94631259_94631471 | 7.29 |
Lrig1 |
leucine-rich repeats and immunoglobulin-like domains 1 |
24160 |
0.17 |
chr14_4727566_4727854 | 7.29 |
Gm3252 |
predicted gene 3252 |
935 |
0.45 |
chr3_98941589_98941740 | 7.29 |
5730437C11Rik |
RIKEN cDNA 5730437C11 gene |
408 |
0.83 |
chrY_90828855_90829206 | 7.28 |
Gm21742 |
predicted gene, 21742 |
8383 |
0.19 |
chr5_4821879_4822030 | 7.27 |
Gm43112 |
predicted gene 43112 |
673 |
0.58 |
chr5_39418984_39419135 | 7.27 |
Gm5291 |
predicted gene 5291 |
16814 |
0.17 |
chr5_9725349_9725654 | 7.27 |
Grm3 |
glutamate receptor, metabotropic 3 |
331 |
0.91 |
chr14_7243589_7243925 | 7.24 |
Gm5456 |
predicted gene 5456 |
2315 |
0.22 |
chr13_73604216_73604826 | 7.24 |
Clptm1l |
CLPTM1-like |
515 |
0.77 |
chr16_59403794_59403959 | 7.22 |
Gabrr3 |
gamma-aminobutyric acid (GABA) receptor, rho 3 |
3456 |
0.19 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.8 | 47.5 | GO:2000019 | negative regulation of male gonad development(GO:2000019) |
6.4 | 32.0 | GO:0019695 | choline metabolic process(GO:0019695) |
3.8 | 7.5 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
3.6 | 83.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
2.6 | 7.8 | GO:0033058 | directional locomotion(GO:0033058) |
2.3 | 20.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
2.2 | 2.2 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
2.0 | 5.9 | GO:0071873 | response to norepinephrine(GO:0071873) |
1.9 | 19.5 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
1.9 | 5.7 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
1.9 | 5.6 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
1.9 | 3.7 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
1.8 | 5.4 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.6 | 3.3 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.6 | 4.8 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.6 | 4.7 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.6 | 4.7 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
1.5 | 7.7 | GO:0071671 | regulation of smooth muscle cell chemotaxis(GO:0071671) |
1.4 | 4.2 | GO:0072092 | ureteric bud invasion(GO:0072092) |
1.4 | 4.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.4 | 4.2 | GO:0002877 | regulation of acute inflammatory response to non-antigenic stimulus(GO:0002877) |
1.4 | 67.3 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
1.4 | 2.7 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.3 | 4.0 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
1.3 | 3.9 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
1.3 | 39.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
1.3 | 3.8 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
1.2 | 4.9 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
1.2 | 2.4 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
1.2 | 3.6 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
1.2 | 1.2 | GO:0072025 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.1 | 3.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
1.1 | 3.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.1 | 5.5 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
1.1 | 3.3 | GO:0052428 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
1.1 | 3.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.1 | 3.2 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
1.1 | 4.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 | 3.2 | GO:0030035 | microspike assembly(GO:0030035) |
1.0 | 4.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.0 | 3.1 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
1.0 | 15.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.0 | 3.0 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.0 | 7.9 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.9 | 3.8 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
0.9 | 2.8 | GO:0030070 | insulin processing(GO:0030070) |
0.9 | 3.7 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.9 | 4.5 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.9 | 4.5 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.9 | 0.9 | GO:0035910 | ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.9 | 6.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.9 | 4.5 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.9 | 1.8 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.9 | 3.5 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.9 | 4.4 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.9 | 5.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.8 | 3.4 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.8 | 2.5 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.8 | 2.5 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.8 | 2.5 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.8 | 3.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.8 | 2.4 | GO:0032672 | regulation of interleukin-3 production(GO:0032672) |
0.8 | 2.4 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.8 | 2.4 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.8 | 2.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
0.8 | 3.1 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
0.8 | 5.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.8 | 0.8 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.8 | 1.5 | GO:0042706 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
0.8 | 3.9 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.8 | 8.4 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.8 | 2.3 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.8 | 2.3 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.7 | 1.5 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.7 | 0.7 | GO:0021847 | ventricular zone neuroblast division(GO:0021847) |
0.7 | 3.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.7 | 2.2 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.7 | 2.2 | GO:0007525 | somatic muscle development(GO:0007525) |
0.7 | 2.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.7 | 2.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.7 | 2.8 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.7 | 1.4 | GO:0048320 | axial mesoderm formation(GO:0048320) |
0.7 | 1.3 | GO:0061153 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.7 | 3.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.7 | 7.3 | GO:0071625 | vocalization behavior(GO:0071625) |
0.7 | 3.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.6 | 4.5 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.6 | 1.2 | GO:0021823 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) |
0.6 | 2.5 | GO:0061055 | myotome development(GO:0061055) |
0.6 | 6.2 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.6 | 4.3 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
0.6 | 3.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.6 | 1.8 | GO:0019660 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
0.6 | 1.8 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.6 | 3.7 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.6 | 3.7 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.6 | 1.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.6 | 14.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.6 | 1.2 | GO:1900157 | regulation of bone mineralization involved in bone maturation(GO:1900157) |
0.6 | 2.9 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
0.6 | 13.4 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.6 | 1.7 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.6 | 2.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.6 | 1.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.6 | 2.3 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.6 | 1.7 | GO:0060437 | lung growth(GO:0060437) |
0.6 | 5.8 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.6 | 1.7 | GO:0019086 | late viral transcription(GO:0019086) |
0.6 | 1.7 | GO:0061309 | cardiac neural crest cell development involved in outflow tract morphogenesis(GO:0061309) |
0.6 | 1.7 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.6 | 1.1 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.5 | 1.1 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
0.5 | 3.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.5 | 9.0 | GO:0009303 | rRNA transcription(GO:0009303) |
0.5 | 12.1 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.5 | 5.8 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.5 | 1.0 | GO:2000809 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) positive regulation of synaptic vesicle clustering(GO:2000809) |
0.5 | 2.0 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.5 | 1.0 | GO:0021564 | vagus nerve development(GO:0021564) |
0.5 | 2.0 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
0.5 | 1.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.5 | 1.5 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 1.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.5 | 1.0 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.5 | 3.4 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.5 | 1.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.5 | 5.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.5 | 4.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.5 | 5.3 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.5 | 3.8 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.5 | 0.5 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.5 | 1.4 | GO:0070103 | regulation of interleukin-6-mediated signaling pathway(GO:0070103) |
0.5 | 1.4 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.5 | 0.5 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.4 | 4.9 | GO:0022038 | corpus callosum development(GO:0022038) |
0.4 | 0.9 | GO:0045715 | negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
0.4 | 1.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 4.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.4 | 1.3 | GO:0099558 | maintenance of synapse structure(GO:0099558) |
0.4 | 1.3 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.4 | 1.3 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.4 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.4 | 1.7 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.4 | 3.0 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.4 | 0.4 | GO:0044337 | canonical Wnt signaling pathway involved in positive regulation of apoptotic process(GO:0044337) |
0.4 | 1.3 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.4 | 2.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.4 | 6.1 | GO:0099514 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 2.0 | GO:1904970 | brush border assembly(GO:1904970) |
0.4 | 1.6 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.4 | 2.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.4 | 1.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.4 | 0.4 | GO:1901656 | glycoside transport(GO:1901656) |
0.4 | 0.8 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.4 | 1.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.4 | 0.8 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.4 | 1.2 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.4 | 4.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.4 | 3.8 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.4 | 1.1 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.4 | 2.2 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.4 | 1.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.4 | 1.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.5 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.4 | 3.3 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.4 | 1.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.4 | 1.8 | GO:0061525 | hindgut development(GO:0061525) |
0.4 | 4.0 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.4 | 1.1 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.4 | 1.1 | GO:0030242 | pexophagy(GO:0030242) |
0.4 | 1.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.4 | 1.4 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.4 | 2.5 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.4 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.3 | 0.7 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
0.3 | 2.4 | GO:0042637 | catagen(GO:0042637) |
0.3 | 1.0 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.3 | 1.4 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.3 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.3 | 1.0 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 0.7 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 1.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.3 | 1.3 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.3 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.3 | 1.0 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.3 | 0.7 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.3 | 1.6 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.3 | 0.6 | GO:0060486 | Clara cell differentiation(GO:0060486) |
0.3 | 6.4 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
0.3 | 2.3 | GO:1903025 | regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903025) |
0.3 | 0.9 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.3 | 2.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.3 | 1.2 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.3 | 1.2 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
0.3 | 0.6 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.3 | 0.3 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 0.9 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.3 | 1.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 1.8 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 0.6 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 0.3 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.3 | 0.3 | GO:0097104 | postsynaptic membrane assembly(GO:0097104) |
0.3 | 0.9 | GO:0070458 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.3 | 0.9 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 0.6 | GO:0060435 | bronchiole development(GO:0060435) |
0.3 | 3.4 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.3 | 2.5 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.3 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.3 | 1.1 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.3 | 1.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.3 | 1.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.3 | 3.7 | GO:0030539 | male genitalia development(GO:0030539) |
0.3 | 0.3 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.3 | 1.3 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.3 | 0.5 | GO:2000705 | regulation of dense core granule biogenesis(GO:2000705) |
0.3 | 1.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 0.8 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.3 | 2.4 | GO:0007614 | short-term memory(GO:0007614) |
0.3 | 1.3 | GO:0051596 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.3 | 2.3 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.3 | 0.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.3 | 0.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.3 | 3.3 | GO:0034389 | lipid particle organization(GO:0034389) |
0.3 | 2.0 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.3 | 1.0 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
0.3 | 0.8 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.3 | 14.7 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.3 | 1.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.3 | 1.3 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.3 | 1.3 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.2 | 0.2 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.2 | 1.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.2 | 0.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 1.2 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.2 | 1.0 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.2 | 1.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.2 | 0.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 1.2 | GO:0010935 | regulation of macrophage cytokine production(GO:0010935) |
0.2 | 0.7 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.2 | 0.7 | GO:0051665 | membrane raft localization(GO:0051665) |
0.2 | 0.5 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.2 | GO:0048382 | mesendoderm development(GO:0048382) |
0.2 | 7.9 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
0.2 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.2 | 0.2 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.2 | 0.5 | GO:0042519 | tyrosine phosphorylation of Stat4 protein(GO:0042504) regulation of tyrosine phosphorylation of Stat4 protein(GO:0042519) |
0.2 | 0.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.2 | 0.5 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
0.2 | 0.9 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
0.2 | 4.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 1.2 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.2 | 0.2 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.5 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.2 | 0.2 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
0.2 | 0.7 | GO:1904304 | regulation of gastro-intestinal system smooth muscle contraction(GO:1904304) |
0.2 | 0.5 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
0.2 | 0.7 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.2 | 0.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.7 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.2 | 0.2 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.2 | 0.7 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.2 | 0.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 1.3 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.7 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.2 | 1.5 | GO:1901160 | serotonin metabolic process(GO:0042428) primary amino compound metabolic process(GO:1901160) |
0.2 | 1.1 | GO:1903551 | regulation of extracellular exosome assembly(GO:1903551) |
0.2 | 0.6 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
0.2 | 1.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.2 | 0.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.2 | 0.2 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.2 | 0.2 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 0.6 | GO:1900045 | negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 | 0.2 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.2 | 0.4 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.2 | 0.2 | GO:0072102 | glomerulus morphogenesis(GO:0072102) |
0.2 | 0.6 | GO:0060005 | vestibular reflex(GO:0060005) |
0.2 | 0.4 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.2 | 1.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.2 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.2 | 4.6 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 0.8 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
0.2 | 1.9 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.4 | GO:0051138 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.2 | 0.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.2 | 0.6 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.8 | GO:0033504 | floor plate development(GO:0033504) |
0.2 | 0.4 | GO:2000015 | regulation of determination of dorsal identity(GO:2000015) |
0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.2 | 2.2 | GO:0003334 | keratinocyte development(GO:0003334) |
0.2 | 1.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.4 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.2 | 1.7 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 2.7 | GO:0001967 | suckling behavior(GO:0001967) |
0.2 | 0.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 1.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.6 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 0.6 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.2 | 0.4 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.2 | 0.4 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 2.4 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 | 0.6 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.2 | 0.5 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.2 | 1.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.9 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.2 | 0.5 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.2 | 0.4 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.2 | 0.9 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.2 | 0.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.2 | 0.4 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.2 | 1.1 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.2 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 0.4 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.2 | 0.4 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.2 | 0.2 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.2 | 0.2 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.2 | 0.9 | GO:0033572 | transferrin transport(GO:0033572) |
0.2 | 1.1 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.2 | 0.5 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 0.2 | GO:1900825 | regulation of membrane depolarization during action potential(GO:0098902) regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.2 | 1.7 | GO:1990403 | embryonic brain development(GO:1990403) |
0.2 | 4.1 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.2 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 0.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.9 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.2 | 0.9 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.3 | GO:0051462 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) |
0.2 | 0.2 | GO:2000698 | positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) |
0.2 | 0.3 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
0.2 | 0.2 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.2 | 1.3 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.2 | 0.7 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.2 | 1.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
0.2 | 0.5 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.2 | 0.5 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.2 | 0.5 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.2 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.2 | 0.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 0.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 0.5 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.2 | 0.3 | GO:0035112 | genitalia morphogenesis(GO:0035112) |
0.2 | 0.8 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.2 | 0.2 | GO:0035934 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 0.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.2 | 0.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.2 | 0.3 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.2 | 0.6 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.2 | 0.6 | GO:0043586 | tongue development(GO:0043586) |
0.2 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.2 | 0.2 | GO:0055026 | negative regulation of cardiac muscle tissue development(GO:0055026) |
0.2 | 0.8 | GO:0032229 | negative regulation of synaptic transmission, GABAergic(GO:0032229) |
0.2 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.2 | 0.6 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.2 | 11.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.1 | 0.3 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
0.1 | 0.7 | GO:0071732 | cellular response to nitric oxide(GO:0071732) |
0.1 | 0.7 | GO:0021860 | pyramidal neuron development(GO:0021860) |
0.1 | 0.1 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.1 | 0.3 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.1 | 0.3 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.1 | 1.5 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.1 | 1.2 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 0.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.1 | 0.3 | GO:1903543 | regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
0.1 | 0.1 | GO:0032532 | regulation of microvillus length(GO:0032532) |
0.1 | 1.1 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 3.8 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 1.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.4 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.7 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 2.2 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.1 | 0.3 | GO:0070295 | renal water absorption(GO:0070295) |
0.1 | 0.7 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.1 | 0.3 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.1 | 0.7 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.4 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
0.1 | 0.3 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.1 | 1.1 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
0.1 | 0.1 | GO:0021775 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.1 | 3.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.3 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.8 | GO:0006971 | hypotonic response(GO:0006971) |
0.1 | 0.5 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 1.1 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.1 | 0.3 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.1 | 0.6 | GO:0035336 | long-chain fatty-acyl-CoA metabolic process(GO:0035336) |
0.1 | 1.0 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.1 | 3.9 | GO:0007588 | excretion(GO:0007588) |
0.1 | 0.6 | GO:0034349 | glial cell apoptotic process(GO:0034349) |
0.1 | 0.2 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.1 | 0.4 | GO:0001546 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.1 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.1 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
0.1 | 0.6 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.1 | 0.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.2 | GO:0021636 | trigeminal nerve morphogenesis(GO:0021636) trigeminal nerve structural organization(GO:0021637) |
0.1 | 0.2 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.1 | 0.6 | GO:1990564 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 | 0.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.1 | 0.2 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.1 | 0.4 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.4 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.1 | 0.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.9 | GO:0009409 | response to cold(GO:0009409) |
0.1 | 0.5 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.1 | 1.9 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.1 | 0.1 | GO:0071224 | cellular response to peptidoglycan(GO:0071224) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 1.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.2 | GO:1903261 | regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.1 | 0.3 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.1 | 0.1 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.1 | 0.2 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
0.1 | 0.6 | GO:0033574 | response to testosterone(GO:0033574) |
0.1 | 0.1 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.1 | 0.1 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 2.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.1 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.3 | GO:0014028 | notochord formation(GO:0014028) |
0.1 | 0.2 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.1 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
0.1 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.1 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.1 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 1.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 0.1 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.1 | 0.1 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
0.1 | 0.5 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.1 | 0.3 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 2.3 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.1 | 0.2 | GO:0061430 | bone trabecula morphogenesis(GO:0061430) |
0.1 | 0.4 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.7 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.2 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 0.4 | GO:0072401 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.1 | 0.2 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.1 | 0.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.1 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.1 | 0.3 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:1902683 | regulation of protein localization to synapse(GO:1902473) regulation of receptor localization to synapse(GO:1902683) |
0.1 | 0.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
0.1 | 0.2 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.2 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
0.1 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.1 | 0.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.1 | 3.4 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
0.1 | 0.4 | GO:0035977 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.1 | 0.5 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.1 | 0.4 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.1 | 0.2 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.1 | 0.2 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.7 | GO:0015858 | nucleoside transport(GO:0015858) |
0.1 | 0.1 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 0.3 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.5 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.7 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.1 | 0.3 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.3 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
0.1 | 0.8 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.3 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.1 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0003348 | cardiac endothelial cell differentiation(GO:0003348) |
0.1 | 1.0 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.1 | 0.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.3 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.1 | 0.3 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.1 | 0.2 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.1 | 0.1 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.9 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.1 | 0.2 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.3 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.1 | 0.1 | GO:1902837 | amino acid import into cell(GO:1902837) |
0.1 | 0.2 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.1 | 0.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 0.8 | GO:0003016 | respiratory system process(GO:0003016) |
0.1 | 0.3 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.1 | 0.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 0.2 | GO:0008355 | olfactory learning(GO:0008355) |
0.1 | 0.2 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.1 | 0.4 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.5 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 0.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 0.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.1 | 1.2 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.1 | 0.5 | GO:1902803 | regulation of synaptic vesicle transport(GO:1902803) |
0.1 | 0.4 | GO:0007379 | segment specification(GO:0007379) |
0.1 | 0.4 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.1 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.1 | GO:0060594 | mammary gland specification(GO:0060594) |
0.1 | 0.1 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.1 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 0.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.1 | GO:0060664 | epithelial cell proliferation involved in salivary gland morphogenesis(GO:0060664) |
0.1 | 0.1 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.1 | 0.2 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 0.3 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.2 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.1 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 0.3 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.1 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.1 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 0.1 | GO:0045423 | granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0042253) regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
0.1 | 0.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.1 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.1 | 0.4 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.1 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 0.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 0.1 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.1 | 0.1 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.1 | 0.4 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.1 | 0.4 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.6 | GO:0000478 | endonucleolytic cleavage involved in rRNA processing(GO:0000478) |
0.1 | 0.1 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.1 | 0.2 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 0.3 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.1 | 0.9 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.1 | 0.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.2 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.1 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.1 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.1 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.3 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.5 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.1 | 0.8 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.1 | 0.1 | GO:0071655 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.1 | 0.5 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.1 | 0.1 | GO:0090296 | regulation of mitochondrial DNA replication(GO:0090296) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.1 | 0.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.1 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.1 | 0.1 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
0.1 | 3.0 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.1 | 0.1 | GO:1901563 | response to camptothecin(GO:1901563) |
0.1 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.7 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.1 | 0.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.1 | GO:1903751 | regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
0.1 | 0.2 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 0.6 | GO:0014850 | response to muscle activity(GO:0014850) |
0.1 | 2.2 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.2 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 0.2 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.1 | 0.4 | GO:0060573 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 2.1 | GO:0010970 | establishment of localization by movement along microtubule(GO:0010970) |
0.1 | 0.2 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.1 | 0.2 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.1 | 1.7 | GO:0008306 | associative learning(GO:0008306) |
0.1 | 1.6 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.2 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.2 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.2 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.0 | 0.0 | GO:0090325 | regulation of locomotion involved in locomotory behavior(GO:0090325) |
0.0 | 0.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
0.0 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.0 | 2.4 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.0 | 0.5 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.1 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.0 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.0 | 0.1 | GO:0043137 | lagging strand elongation(GO:0006273) DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.1 | GO:0010958 | regulation of amino acid import(GO:0010958) L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.0 | 0.1 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.4 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.0 | 0.2 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.0 | 0.1 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
0.0 | 0.0 | GO:0008212 | mineralocorticoid metabolic process(GO:0008212) |
0.0 | 0.2 | GO:0030204 | chondroitin sulfate metabolic process(GO:0030204) |
0.0 | 0.0 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.1 | GO:0008050 | female courtship behavior(GO:0008050) |
0.0 | 0.2 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.0 | GO:0090135 | actin filament branching(GO:0090135) |
0.0 | 0.2 | GO:2000197 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.0 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.0 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.0 | 0.5 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.0 | 0.2 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.0 | 0.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.0 | 0.2 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.7 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.0 | 1.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.0 | 0.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.2 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0086012 | membrane depolarization during cardiac muscle cell action potential(GO:0086012) |
0.0 | 0.1 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.0 | GO:0021825 | substrate-dependent cerebral cortex tangential migration(GO:0021825) |
0.0 | 0.1 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.2 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.0 | 0.2 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
0.0 | 2.4 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.0 | 0.4 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0048243 | regulation of norepinephrine secretion(GO:0014061) norepinephrine secretion(GO:0048243) |
0.0 | 0.1 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.0 | 0.0 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.9 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.1 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
0.0 | 0.6 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.0 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.0 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.0 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.0 | 0.1 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.0 | 0.0 | GO:0032849 | regulation of cellular pH reduction(GO:0032847) positive regulation of cellular pH reduction(GO:0032849) |
0.0 | 0.2 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.0 | GO:0072202 | cell differentiation involved in metanephros development(GO:0072202) |
0.0 | 0.7 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.0 | 0.1 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.0 | 1.0 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.0 | 0.0 | GO:0061365 | positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 | 0.2 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.0 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.0 | 0.0 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.0 | 0.0 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.0 | 0.1 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.8 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.0 | GO:0071670 | smooth muscle cell chemotaxis(GO:0071670) |
0.0 | 0.2 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 0.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.2 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.0 | 0.1 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:0032875 | regulation of DNA endoreduplication(GO:0032875) DNA endoreduplication(GO:0042023) |
0.0 | 0.1 | GO:0072178 | nephric duct development(GO:0072176) nephric duct morphogenesis(GO:0072178) |
0.0 | 0.5 | GO:0030488 | tRNA methylation(GO:0030488) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0019244 | lactate biosynthetic process from pyruvate(GO:0019244) lactate biosynthetic process(GO:0019249) |
0.0 | 0.1 | GO:0046836 | glycolipid transport(GO:0046836) |
0.0 | 0.0 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.0 | 0.2 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.0 | 0.2 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
0.0 | 0.1 | GO:0072578 | neurotransmitter-gated ion channel clustering(GO:0072578) |
0.0 | 0.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.2 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.1 | GO:0032226 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) |
0.0 | 0.1 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.3 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.0 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.0 | 0.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.0 | 0.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.0 | 0.0 | GO:1903078 | positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.0 | 0.0 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.0 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.0 | 0.0 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.0 | 0.1 | GO:0048664 | neuron fate determination(GO:0048664) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.1 | GO:1902075 | cellular response to salt(GO:1902075) |
0.0 | 0.0 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.0 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.1 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
0.0 | 0.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.0 | 0.1 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.0 | 0.5 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.0 | 0.5 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.0 | 0.1 | GO:0045113 | integrin biosynthetic process(GO:0045112) regulation of integrin biosynthetic process(GO:0045113) |
0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.0 | 0.1 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 0.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.0 | 0.0 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.0 | 0.0 | GO:1903818 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.0 | 0.7 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.2 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.0 | GO:0003383 | apical constriction(GO:0003383) |
0.0 | 0.4 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.0 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.0 | 0.0 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.0 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.0 | 0.1 | GO:1990774 | regulation of tumor necrosis factor secretion(GO:1904467) tumor necrosis factor secretion(GO:1990774) |
0.0 | 0.1 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.1 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.3 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.0 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.0 | 0.0 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.0 | 0.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.0 | 0.1 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.0 | 0.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0033034 | positive regulation of myeloid cell apoptotic process(GO:0033034) |
0.0 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.0 | 0.0 | GO:1900376 | regulation of melanin biosynthetic process(GO:0048021) negative regulation of melanin biosynthetic process(GO:0048022) regulation of secondary metabolite biosynthetic process(GO:1900376) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.0 | 0.0 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.0 | 0.8 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.0 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.0 | 0.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.0 | 0.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.0 | 0.1 | GO:1903966 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
0.0 | 0.1 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.0 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.0 | 0.7 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.0 | 0.0 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.0 | 0.1 | GO:0002063 | chondrocyte development(GO:0002063) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 | 0.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.0 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.0 | 0.2 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.0 | 0.1 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.1 | GO:0031034 | myosin filament assembly(GO:0031034) |
0.0 | 0.0 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.0 | 0.0 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.0 | 0.1 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.0 | 0.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.0 | 0.0 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
0.0 | 0.0 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.0 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.0 | 0.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.0 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.0 | 1.3 | GO:0045665 | negative regulation of neuron differentiation(GO:0045665) |
0.0 | 0.0 | GO:0051797 | regulation of hair follicle development(GO:0051797) |
0.0 | 0.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
0.0 | 0.0 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.0 | 0.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.0 | 0.0 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.0 | 0.0 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.0 | 0.1 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.0 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.0 | 0.0 | GO:0007403 | glial cell fate determination(GO:0007403) |
0.0 | 0.0 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.0 | 0.0 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.0 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.0 | 0.1 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.2 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
0.0 | 0.0 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.2 | GO:0048663 | neuron fate commitment(GO:0048663) |
0.0 | 0.0 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.0 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:1903861 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
0.0 | 0.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.0 | 0.0 | GO:0001998 | angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) |
0.0 | 0.0 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.3 | GO:0006284 | base-excision repair(GO:0006284) |
0.0 | 0.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.0 | 0.0 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
0.0 | 0.2 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.0 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
0.0 | 0.0 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.0 | 0.0 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.0 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
0.0 | 0.0 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
0.0 | 0.0 | GO:1901977 | negative regulation of cell cycle checkpoint(GO:1901977) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 31.7 | GO:0071986 | Ragulator complex(GO:0071986) |
3.0 | 14.9 | GO:0071547 | piP-body(GO:0071547) |
2.4 | 7.2 | GO:0097451 | glial limiting end-foot(GO:0097451) |
1.9 | 5.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.5 | 3.1 | GO:0044393 | microspike(GO:0044393) |
1.4 | 4.3 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
1.2 | 3.6 | GO:0038037 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.2 | 12.8 | GO:0042555 | MCM complex(GO:0042555) |
1.1 | 5.6 | GO:0097433 | dense body(GO:0097433) |
1.1 | 7.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
1.1 | 8.6 | GO:0097449 | astrocyte projection(GO:0097449) |
1.0 | 6.2 | GO:0031258 | lamellipodium membrane(GO:0031258) |
1.0 | 4.1 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.9 | 2.8 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.9 | 7.0 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.9 | 3.5 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.9 | 3.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.9 | 5.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.8 | 2.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 3.3 | GO:1990246 | uniplex complex(GO:1990246) |
0.8 | 2.3 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.8 | 3.8 | GO:0005579 | membrane attack complex(GO:0005579) |
0.7 | 2.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.7 | 2.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.7 | 2.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.7 | 5.9 | GO:0005883 | neurofilament(GO:0005883) |
0.6 | 7.6 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.6 | 8.0 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.6 | 8.9 | GO:0043205 | fibril(GO:0043205) |
0.6 | 5.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.6 | 4.6 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.5 | 2.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 4.6 | GO:0036128 | CatSper complex(GO:0036128) |
0.5 | 2.4 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.5 | 1.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.5 | 3.4 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.5 | 6.7 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 2.3 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.4 | 1.3 | GO:0042585 | germinal vesicle(GO:0042585) |
0.4 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 1.3 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.4 | 61.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.4 | 1.2 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.4 | 3.3 | GO:0036157 | outer dynein arm(GO:0036157) |
0.4 | 1.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.4 | 16.0 | GO:0045095 | keratin filament(GO:0045095) |
0.4 | 5.3 | GO:0031045 | dense core granule(GO:0031045) |
0.4 | 1.1 | GO:0048179 | activin receptor complex(GO:0048179) |
0.3 | 5.4 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.3 | 5.7 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.3 | 1.0 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.3 | 3.9 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 8.7 | GO:0016235 | aggresome(GO:0016235) |
0.3 | 0.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.3 | 1.1 | GO:0070545 | PeBoW complex(GO:0070545) |
0.3 | 1.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.3 | 3.0 | GO:0043194 | axon initial segment(GO:0043194) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 2.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.3 | 0.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 1.6 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.3 | 1.0 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.2 | 1.2 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.2 | 0.7 | GO:0036396 | MIS complex(GO:0036396) |
0.2 | 1.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 2.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 1.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 2.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 0.7 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.2 | 2.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 2.0 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 1.3 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.2 | 0.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 2.5 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.2 | 1.7 | GO:0030056 | hemidesmosome(GO:0030056) |
0.2 | 2.0 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.2 | 0.6 | GO:0071797 | LUBAC complex(GO:0071797) |
0.2 | 1.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 2.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.2 | 1.1 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 2.6 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 0.5 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.2 | 1.4 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.8 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 1.0 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.2 | 3.6 | GO:0030057 | desmosome(GO:0030057) |
0.2 | 0.5 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.2 | 1.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.2 | 5.5 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 0.9 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.9 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 0.5 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.1 | 0.7 | GO:0045180 | basal cortex(GO:0045180) |
0.1 | 0.7 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.7 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.1 | 14.6 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 1.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 1.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 8.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.1 | 0.9 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.1 | 0.4 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.1 | 1.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 1.6 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 1.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 2.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 0.4 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.1 | 0.7 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.8 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 0.3 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 1.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.4 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.2 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 0.2 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.1 | 0.2 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 0.3 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 1.0 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 2.3 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.1 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.1 | 0.6 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 0.3 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.1 | 0.3 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.8 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 0.4 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 0.5 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.1 | 4.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 20.3 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.6 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.1 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.1 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.1 | 0.6 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 10.0 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.1 | 0.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 1.2 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 1.1 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.1 | 0.2 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.8 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 0.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.1 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.1 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 0.2 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.0 | 0.7 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.0 | 0.3 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.1 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 0.8 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.0 | 0.1 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.2 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 8.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 0.2 | GO:0090543 | Flemming body(GO:0090543) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.5 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.2 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
0.0 | 0.1 | GO:0000938 | GARP complex(GO:0000938) |
0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
0.0 | 1.6 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.0 | 0.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 2.4 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.0 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.0 | 0.9 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 1.5 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 0.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.1 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.3 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 1.0 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.0 | 0.2 | GO:0043073 | germ cell nucleus(GO:0043073) |
0.0 | 0.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.1 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.1 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.0 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 1.1 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.0 | 0.0 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.0 | 0.1 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.1 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 0.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.0 | 0.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.0 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.5 | 84.4 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
4.2 | 33.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
3.2 | 9.5 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
2.1 | 6.2 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.8 | 12.9 | GO:0003680 | AT DNA binding(GO:0003680) |
1.5 | 4.4 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
1.4 | 4.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.4 | 10.0 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) |
1.4 | 4.3 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
1.4 | 5.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 4.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.1 | 13.5 | GO:0016595 | glutamate binding(GO:0016595) |
1.0 | 3.1 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
1.0 | 3.1 | GO:0043398 | HLH domain binding(GO:0043398) |
1.0 | 88.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
1.0 | 3.9 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
1.0 | 3.9 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
1.0 | 10.6 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.9 | 2.8 | GO:0097016 | L27 domain binding(GO:0097016) |
0.9 | 3.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.9 | 2.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
0.8 | 2.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.8 | 3.3 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.8 | 6.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.8 | 4.7 | GO:0016151 | nickel cation binding(GO:0016151) |
0.8 | 2.3 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.7 | 2.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.7 | 2.2 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.7 | 2.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.7 | 2.1 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.7 | 4.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.7 | 8.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.7 | 3.3 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.7 | 2.6 | GO:0002134 | UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.6 | 2.6 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.6 | 1.9 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.6 | 4.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.6 | 1.8 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.6 | 2.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.6 | 2.4 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.6 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.6 | 2.8 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.6 | 1.1 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.5 | 4.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.5 | 8.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.5 | 4.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.5 | 1.5 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.5 | 1.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.5 | 3.5 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.5 | 2.0 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.5 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.5 | 2.4 | GO:0034916 | 4-methyloctanoyl-CoA dehydrogenase activity(GO:0034580) naphthyl-2-methyl-succinyl-CoA dehydrogenase activity(GO:0034845) 2-methylhexanoyl-CoA dehydrogenase activity(GO:0034916) propionyl-CoA dehydrogenase activity(GO:0043820) thiol-driven fumarate reductase activity(GO:0043830) coenzyme F420-dependent 2,4,6-trinitrophenol reductase activity(GO:0052758) coenzyme F420-dependent 2,4,6-trinitrophenol hydride reductase activity(GO:0052759) coenzyme F420-dependent 2,4-dinitrophenol reductase activity(GO:0052760) |
0.5 | 1.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 1.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.5 | 2.4 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.5 | 6.4 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.5 | 0.9 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 2.2 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 5.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 2.2 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.4 | 0.4 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
0.4 | 7.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.4 | 3.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.4 | 2.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.4 | 26.4 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.4 | 1.2 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.4 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.2 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.4 | 1.6 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.4 | 1.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.4 | 34.2 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.4 | 5.0 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 26.2 | GO:0015171 | amino acid transmembrane transporter activity(GO:0015171) |
0.4 | 0.8 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.4 | 2.2 | GO:0070191 | methionine-R-sulfoxide reductase activity(GO:0070191) |
0.4 | 1.1 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.4 | 1.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.4 | 4.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.4 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.3 | 4.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.3 | 7.6 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.3 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 0.3 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.3 | 4.0 | GO:0019841 | retinol binding(GO:0019841) |
0.3 | 2.9 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.3 | 4.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 2.8 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.3 | 0.9 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 2.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.3 | 5.1 | GO:0031489 | myosin V binding(GO:0031489) |
0.3 | 5.7 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.3 | 1.2 | GO:0015265 | urea channel activity(GO:0015265) |
0.3 | 3.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 2.6 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.3 | 1.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.3 | 0.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.3 | 1.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.3 | 5.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.3 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.3 | 1.7 | GO:0048495 | Roundabout binding(GO:0048495) |
0.3 | 1.1 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.3 | 1.1 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.3 | 1.1 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 0.8 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.3 | 2.9 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.3 | 1.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.3 | 1.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.2 | 2.2 | GO:0070513 | death domain binding(GO:0070513) |
0.2 | 6.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.2 | 4.4 | GO:0030506 | ankyrin binding(GO:0030506) |
0.2 | 1.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.2 | 3.6 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 10.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.2 | 1.4 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 2.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.2 | 0.5 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.2 | 0.7 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.2 | 0.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 0.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 0.7 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.2 | 1.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.5 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 1.9 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.2 | 0.6 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.6 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.8 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.6 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 0.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.2 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.2 | 1.4 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 0.4 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 2.5 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 12.9 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 0.2 | GO:0001091 | RNA polymerase II basal transcription factor binding(GO:0001091) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 0.7 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.2 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.2 | 3.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 2.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.2 | 0.5 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 2.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 0.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.2 | 0.9 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.2 | 2.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 1.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.2 | 4.4 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.2 | 1.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 0.9 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 7.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.2 | 0.5 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.2 | 0.5 | GO:0030172 | troponin C binding(GO:0030172) |
0.2 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
0.2 | 1.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.2 | 0.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.2 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.2 | 1.4 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 5.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.2 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 1.1 | GO:0043047 | single-stranded telomeric DNA binding(GO:0043047) G-rich strand telomeric DNA binding(GO:0098505) |
0.2 | 0.8 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.2 | 2.4 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.2 | 1.3 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.3 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 4.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.3 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.2 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.2 | 0.5 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.1 | 0.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.1 | 4.0 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.6 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 0.7 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.1 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 0.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 1.4 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 1.4 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.1 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.7 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.4 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.7 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:0016428 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 0.8 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 0.4 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.1 | 0.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 0.1 | GO:0004954 | prostanoid receptor activity(GO:0004954) |
0.1 | 0.5 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.5 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 1.0 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.1 | 2.3 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.1 | 2.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 3.9 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 10.8 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 5.9 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.4 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.1 | GO:0036222 | XTP diphosphatase activity(GO:0036222) |
0.1 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 1.2 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 3.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.1 | 8.1 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.1 | 0.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.4 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 2.6 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.1 | 0.1 | GO:0030284 | estrogen receptor activity(GO:0030284) |
0.1 | 1.3 | GO:0031404 | chloride ion binding(GO:0031404) |
0.1 | 0.2 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.1 | 3.1 | GO:0043914 | NADPH:sulfur oxidoreductase activity(GO:0043914) |
0.1 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.1 | 0.5 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.4 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.2 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 3.9 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 0.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 1.3 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 0.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 1.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 3.5 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 1.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 0.2 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.1 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.1 | 1.2 | GO:0016896 | 3'-5'-exoribonuclease activity(GO:0000175) exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.1 | 0.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.5 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.2 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.1 | 0.3 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.5 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.4 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.1 | 0.3 | GO:0003958 | NADPH-hemoprotein reductase activity(GO:0003958) |
0.1 | 0.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 1.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 3.1 | GO:0044823 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.1 | 0.4 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.1 | 0.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.9 | GO:0030553 | cGMP binding(GO:0030553) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.9 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.1 | 0.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 0.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.1 | 1.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.6 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.1 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.1 | 1.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.1 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 0.2 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.1 | 0.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 0.1 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 1.1 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.4 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.3 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.2 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.0 | GO:0008193 | tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.7 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.0 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.1 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 3.9 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.0 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.5 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.1 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
0.0 | 0.1 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.0 | 0.2 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.0 | 0.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.2 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.1 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.0 | 0.1 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.1 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.1 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.3 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.0 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.1 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.9 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 1.3 | GO:0008146 | sulfotransferase activity(GO:0008146) |
0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.0 | 0.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.0 | 0.1 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.0 | 0.9 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.0 | 0.2 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.0 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.2 | GO:0001163 | RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.0 | 0.1 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.1 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 0.0 | GO:0046921 | alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0042281 | dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity(GO:0042281) |
0.0 | 0.1 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.0 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.0 | 0.4 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.0 | 0.0 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.1 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.0 | 0.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.0 | 0.0 | GO:1990188 | euchromatin binding(GO:1990188) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.0 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.0 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.2 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.0 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.0 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.0 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.0 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 0.1 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 0.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.0 | 0.0 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.0 | 0.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.0 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.0 | 0.0 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.0 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.4 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.0 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.0 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.2 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.0 | GO:0070052 | collagen V binding(GO:0070052) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 79.3 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.3 | 2.6 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.6 | 15.1 | PID REELIN PATHWAY | Reelin signaling pathway |
0.5 | 7.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 1.4 | PID EPO PATHWAY | EPO signaling pathway |
0.4 | 5.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 1.4 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 19.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.4 | 10.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.3 | 5.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.3 | 3.0 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 8.5 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 7.5 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 4.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.2 | 3.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 0.5 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 1.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.2 | 4.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 4.8 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 4.4 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 1.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 5.4 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 1.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.9 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 3.3 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 0.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.1 | 0.1 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 1.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 3.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 0.7 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 11.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.1 | 1.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.5 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 0.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.5 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.1 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.1 | 0.2 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.3 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.1 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.7 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.4 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.1 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.1 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.0 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 91.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
1.2 | 13.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.9 | 12.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.8 | 1.6 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.7 | 7.4 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.6 | 5.4 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.6 | 8.9 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.5 | 1.4 | REACTOME SIGNALING BY FGFR IN DISEASE | Genes involved in Signaling by FGFR in disease |
0.5 | 8.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.4 | 9.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 3.7 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.4 | 4.6 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.4 | 4.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.3 | 3.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.3 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.3 | 4.4 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.3 | 2.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 7.8 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 3.7 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 5.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.3 | 5.4 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 5.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.2 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.2 | 3.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 0.4 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.2 | 1.8 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 4.9 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.2 | 1.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 0.2 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 0.7 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 4.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.2 | 7.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 0.5 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 6.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.2 | 2.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 3.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 3.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 2.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.1 | 3.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.1 | 1.6 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 3.3 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 3.1 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 1.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.1 | 4.3 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.9 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 1.8 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 4.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.1 | 0.8 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.1 | 0.7 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.2 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.1 | 0.6 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 2.1 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.1 | 1.6 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 0.4 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
0.1 | 0.3 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.1 | 1.3 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 0.6 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 0.7 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.1 | 0.1 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.1 | 0.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.7 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.1 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 0.2 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 0.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 1.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.1 | 1.2 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.1 | 0.2 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 1.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 1.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.6 | REACTOME RNA POL III TRANSCRIPTION | Genes involved in RNA Polymerase III Transcription |
0.1 | 3.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 1.1 | REACTOME KINESINS | Genes involved in Kinesins |
0.1 | 0.5 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.0 | 1.0 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 0.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.5 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 0.7 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.3 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 1.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.0 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.9 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 1.0 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.2 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.1 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.0 | 0.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.0 | REACTOME PLATELET HOMEOSTASIS | Genes involved in Platelet homeostasis |
0.0 | 0.0 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |